{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:58Z","timestamp":1786119178962,"version":"build-2736575974"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/bor.0b013e3282f370d1","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T21:56:08Z","timestamp":1236203768000},"page":"3-9","source":"Crossref","is-referenced-by-count":34,"title":["Challenges in the management of microscopic polyangiitis: past, present and future"],"prefix":"10.1097","volume":"20","author":[{"given":"David","family":"Jayne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF01947911","article-title":"A microscopic form of polyarteritis nodosa","volume":"246","author":"Wohlwill","year":"1923","journal-title":"Arch Path Anat Physiol Klin Med"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM195304302481805","article-title":"Periarteritis nodosa and other forms of necrotizing angiitis","volume":"248","author":"Zeek","year":"1953","journal-title":"N Engl J Med"},{"key":"R3-3-20210128","first-page":"214","article-title":"A case of microscopic polyarteritis associated with antineutrophil cytoplasmic antibodies","volume":"27","author":"Feehally","year":"1987","journal-title":"Clin Nephrol"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.10922","article-title":"Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients","volume":"49","author":"Guillevin","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides: proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/ndt\/gfh830","article-title":"ANCA-negative pauci-immune renal vasculitis: histology and outcome","volume":"20","author":"Eisenberger","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1681\/ASN.2006091021","article-title":"Antineutrophil cytoplasmic autoantibody-negative Pauci-immune crescentic glomerulonephritis","volume":"18","author":"Chen","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1136\/hrt.2005.060525","article-title":"Vasculitis masquerading as aortic valve endocarditis","volume":"91","author":"Iqbal","year":"2005","journal-title":"Heart"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/j.ajkd.2007.01.021","article-title":"Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis","volume":"49","author":"Yu","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/rheumatology\/keh374","article-title":"Malignancy is increased in ANCA-associated vasculitis","volume":"43","author":"Pankhurst","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.exger.2004.05.004","article-title":"The clinical and pathological characteristics of Chinese elderly patients with antineutrophil cytoplasmic autoantibodies associated small vessel vasculitis","volume":"39","author":"Wang","year":"2004","journal-title":"Exp Gerontol"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11926-005-0036-5","article-title":"Epidemiology of systemic vasculitis","volume":"7","author":"Lane","year":"2005","journal-title":"Curr Rheumatol Rep"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2215\/CJN.01461005","article-title":"Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan","volume":"1","author":"Fujimoto","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","article-title":"Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups","volume":"61","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1681\/ASN.2005080870","article-title":"Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement","volume":"17","author":"de Lind van Wijngaarden","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1046\/j.1523-1755.2002.00605.x","article-title":"Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients","volume":"62","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/ajkd.2003.50115","article-title":"An index for renal outcome in ANCA-associated glomerulonephritis","volume":"41","author":"Vergunst","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1681\/ASN.2007010066","article-title":"Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis","volume":"18","author":"de Lind van Wijngaarden","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00415-005-0833-9","article-title":"Primary and secondary vasculitic neuropathy","volume":"252","author":"Said","year":"2005","journal-title":"J Neurol"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/jnnp.2006.111013","article-title":"Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis","volume":"78","author":"Cattaneo","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1843.2004.00581.x","article-title":"Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides","volume":"9","author":"Homma","year":"2004","journal-title":"Respirology"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/pgmj.2005.034215","article-title":"Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre","volume":"81","author":"Chen","year":"2005","journal-title":"Postgrad Med J"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-510X(02)00015-1","article-title":"Frequency and patterns of subclinical cognitive impairment in patients with ANCA-associated small vessel vasculitides","volume":"195","author":"Mattioli","year":"2002","journal-title":"J Neurol Sci"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0025-6196(11)63594-5","article-title":"Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group","volume":"72","author":"Jayne","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00002281-200101000-00003","article-title":"Diffuse alveolar hemorrhage syndromes","volume":"13","author":"Specks","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5414\/CNP64480","article-title":"What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides","volume":"64","author":"de Groot","year":"2005","journal-title":"Clin Nephrol"},{"key":"R33-3-20210128","first-page":"759","article-title":"HS, Bhat A, Aravindan et al. Spectrum of renal failure in elderly patients.","volume":"38","year":"2006","journal-title":"Int Urol Nephrol"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/rheumatology\/kem029","article-title":"Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis","volume":"46","author":"Metzler","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2006.060301","article-title":"Induction of remission in active antineutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide","volume":"66","author":"Stassen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegeners granulomatosis.","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/rheumatology\/kei272","article-title":"Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment","volume":"45","author":"Sanders","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R38-3-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1196\/annals.1381.002","article-title":"Atherosclerosis in ANCA-associated vasculitides","volume":"1107","author":"Pagnoux","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R39-3-20210128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","article-title":"Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study","volume":"142","author":"Merkel","year":"2005","journal-title":"Ann Intern Med"},{"key":"R40-3-20210128","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.20002","article-title":"Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation","volume":"50","author":"Booth","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R41-3-20210128","first-page":"2488","article-title":"Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis: report from OMERACT 7","volume":"32","author":"Merkel","year":"2005","journal-title":"J Rheumatol"},{"key":"R42-3-20210128","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on ANCA-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R43-3-20210128","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/ndt\/gfh487","article-title":"Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis","volume":"19","author":"Tam","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R44-3-20210128","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/ndt\/gfi117","article-title":"A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis","volume":"20","author":"Joy","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R45-3-20210128","doi-asserted-by":"crossref","first-page":"c100","DOI":"10.1159\/000089667","article-title":"Mycophenolate mofetil in antineutrophil cytoplasm antibodies-associated systemic vasculitis","volume":"102","author":"Koukoulaki","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"R46-3-20210128","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.20240","article-title":"Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis","volume":"51","author":"Langford","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R47-3-20210128","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","article-title":"Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement","volume":"10","author":"Nowack","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R48-3-20210128","doi-asserted-by":"crossref","first-page":"c35","DOI":"10.1159\/000088313","article-title":"Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis","volume":"102","author":"Ito-Ihara","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"R49-3-20210128","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2005060616","article-title":"Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of antineutrophil cytoplasm antibody-associated systemic vasculitis","volume":"17","author":"Little","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R50-3-20210128","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1681\/ASN.2005121359","article-title":"Is there a role for TNF-alpha in antineutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases","volume":"17","author":"Feldmann","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R51-3-20210128","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.21869","article-title":"Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial","volume":"54","author":"Stone","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R52-3-20210128","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNFalpha blockade with infliximab in antineutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R53-3-20210128","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1096\/fj.05-3841com","article-title":"TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury","volume":"19","author":"Al-Lamki","year":"2005","journal-title":"FASEB J"},{"key":"R54-3-20210128","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.ki.5000167","article-title":"IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis","volume":"69","author":"Hewins","year":"2006","journal-title":"Kidney Int"},{"key":"R55-3-20210128","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.ki.5002395","article-title":"Rituximab in the treatment of antineutrophil cytoplasm antibody associated vasculitis and systemic lupus erythematosus: past, present and future","volume":"72","author":"Walsh","year":"2007","journal-title":"Kidney Int"},{"key":"R57-3-20210128","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/art.22046","article-title":"Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment","volume":"54","author":"Smith","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R58-3-20210128","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.ki.5002371","article-title":"Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis","volume":"72","author":"Alcorta","year":"2007","journal-title":"Kidney Int"},{"key":"R59-3-20210128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2164-8-64","article-title":"Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification","volume":"8","author":"Lyons","year":"2007","journal-title":"BMC Genomics"},{"key":"R60-3-20210128","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/art.22741","article-title":"Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis","volume":"56","author":"Guilpain","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e3282f370d1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:45:31Z","timestamp":1786038331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200801000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3282f370d1","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}